Pharma Journalist -

Cellares has partnered with Taiwanese cell therapy company GenomeFrontier Therapeutics to evaluate automated manufacturing for GF-CART01, an investigational CAR-T cell therapy being…
Read More...

Novo Nordisk has partnered with artificial intelligence company Anthropic to use AI to speed up drug discovery, support research and improve software development across its…
Read More...

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop genetic medicine treatments for diseases affecting the…
Read More...

Gilead Sciences has signed a new agreement with the Pan American Health Organization (PAHO) to help expand access to twice-yearly lenacapavir for HIV prevention across Latin America and…
Read More...

The journey from RNA-targeting concept to clinical reality will be a key focus at the upcoming 9th Annual RNA-Targeted Drug Discovery & Development Summit in Boston this November.…
Read More...

Novo Nordisk has unveiled a major rebrand as it begins what the company describes as its next chapter, introducing the single name “Novo” and a new brand platform built around the…
Read More...

Schrödinger has launched a new biotechnology company, Tectora, to develop potential treatments for immunology and inflammatory diseases. The company was co-founded by Schrödinger, New…
Read More...

CordenPharma is investing €80 million to expand its sterile injectable manufacturing capabilities at its Caponago site near Milan, Italy. The long-term investment program includes…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Bayer’s HYRNUO (sevabertinib) as a first-line treatment for adults with locally advanced or metastatic…
Read More...

Encoded Therapeutics has raised $275 million in a new financing round to advance its genetic medicine programs for severe neurological disorders, including its lead candidate ETX101 for…
Read More...